146 related articles for article (PubMed ID: 7678497)
21. Fibrinolysis and fibrinogenolysis by Val442-plasmin.
Ney KA; Pizzo SV
Biochim Biophys Acta; 1982 Nov; 708(2):218-24. PubMed ID: 6216916
[TBL] [Abstract][Full Text] [Related]
22. Fibrin(-ogen) interactions with plasmin.
Gaffney PJ
Haemostasis; 1977; 6(1):2-25. PubMed ID: 140113
[TBL] [Abstract][Full Text] [Related]
23. Interaction of one-chain and two-chain tissue plasminogen activator with intact and plasmin-degraded fibrin.
Higgins DL; Vehar GA
Biochemistry; 1987 Dec; 26(24):7786-91. PubMed ID: 2962641
[TBL] [Abstract][Full Text] [Related]
24. Different inhibitors of plasmin differentially affect angiostatin production and angiogenesis.
Hatziapostolou M; Katsoris P; Papadimitriou E
Eur J Pharmacol; 2003 Jan; 460(1):1-8. PubMed ID: 12535853
[TBL] [Abstract][Full Text] [Related]
25. Regulation of macrophage receptor-bound plasmin by autoproteolysis.
Falcone DJ; Borth W; McCaffrey TA; Mathew J; McAdam K
J Biol Chem; 1994 Dec; 269(51):32660-6. PubMed ID: 7528219
[TBL] [Abstract][Full Text] [Related]
26. Extrinsic plasminogen activator: a new principle in fibrinolysis.
Lijnen HR
Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
[TBL] [Abstract][Full Text] [Related]
27. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
[TBL] [Abstract][Full Text] [Related]
28. Regulation of streptokinase-human plasmin complex by the plasma proteinase inhibitors alpha 2-antiplasmin and alpha 2-macroglobulin is species specific and temperature dependent.
Gonias SL; Figler NL; Braud LL
Blood; 1988 Nov; 72(5):1658-64. PubMed ID: 2460159
[TBL] [Abstract][Full Text] [Related]
29. The fibrin(ogen)olytic properties of cathepsin D.
Simon DI; Ezratty AM; Loscalzo J
Biochemistry; 1994 May; 33(21):6555-63. PubMed ID: 8204591
[TBL] [Abstract][Full Text] [Related]
30. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
Sugiyama N; Iwamoto M; Abiko Y
Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
[TBL] [Abstract][Full Text] [Related]
31. Plasmin potency estimates: influence of the substrate used in assay.
Philo RD; Gaffney PJ
Thromb Haemost; 1981 Apr; 45(2):107-9. PubMed ID: 6454987
[TBL] [Abstract][Full Text] [Related]
32. Interaction of staphylokinase with different molecular forms of plasminogen.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1993 Jan; 211(1-2):91-7. PubMed ID: 8425556
[TBL] [Abstract][Full Text] [Related]
33. The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin.
Nesheim M; Fredenburgh JC; Larsen GR
J Biol Chem; 1990 Dec; 265(35):21541-8. PubMed ID: 2123871
[TBL] [Abstract][Full Text] [Related]
34. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
Suenson E; Thorsen S
Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
[TBL] [Abstract][Full Text] [Related]
35. Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites.
Tsurupa G; Yakovlev S; McKee P; Medved L
Biochemistry; 2010 Sep; 49(35):7643-51. PubMed ID: 20687529
[TBL] [Abstract][Full Text] [Related]
36. Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells.
Turner JS; Redpath GT; Humphries JE; Gonias SL; Vandenberg SR
Biochem J; 1994 Jan; 297 ( Pt 1)(Pt 1):175-9. PubMed ID: 8280096
[TBL] [Abstract][Full Text] [Related]
37. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
Goodwin CA; Kakkar VV; Scully MF
Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588
[TBL] [Abstract][Full Text] [Related]
38. A fluorescence quench and dequench assay of fibrinogen polymerization, fibrinogenolysis, or fibrinolysis.
Wu JH; Diamond SL
Anal Biochem; 1995 Jan; 224(1):83-91. PubMed ID: 7710120
[TBL] [Abstract][Full Text] [Related]
39. On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin.
Lijnen HR; Van Hoef B; Matsuo O; Collen D
Biochim Biophys Acta; 1992 Jan; 1118(2):144-8. PubMed ID: 1730031
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
Sakai M; Watanuki M; Matsuo O
Biochem Biophys Res Commun; 1989 Jul; 162(2):830-7. PubMed ID: 2527034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]